Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

BOND vs IBB: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, BOND returned −1.4% to IBB's +37.5%, and IBB charges 0.44% to BOND's 0.54%.

askIQ about this page

askIQ about BOND and IBB

Net assets: $8.3bn on Jun 30, 2026 for PIMCO Active Bond Exchange-Traded Fund, and $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF.

At a glance
−1.4%
BOND total return, 1 year
+37.5%
IBB total return, 1 year
0.54%
BOND expense ratio
0.44%
IBB expense ratio

Pair scorecard

IBB costs 0.10 points a year less; their one-year returns differ by 38.9 points.

BOND vs IBB: Differences, Returns & Fees
MeasureBONDIBB
Return
Total return, 1 year−1.4%+37.5%
Drawdown
Below its high3.1%, high on Feb 27, 2026
Benchmark
What it tracksNo index, actively managedBiotech
Cost and size
Expense ratio0.54%0.44%
Net assets, BOND as of Jun 30, 2026 and IBB as of Oct 27, 2026$8.3bn$11.0bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
In the S&P 500, by weight40%
Top ten holdings, share of the fund50%

Holdings in common uses holdings dated Jun 30, 2026 and Oct 27, 2026. Method

Risk and return

Mar 9, 2012 to Oct 23, 2026 · 763 weekly returns
BOND IBB
Return
Total return edge IBB +47.4% +440.1%
Annualized edge IBB +2.7% +12.2%
Price return edge IBB −12.6% +421.9%
Risk
Volatility edge BOND 4.9% 23.0%
Max drawdown edge BOND −19.5% −37.5%
Risk-adjusted
Sharpe edge IBB 0.21 0.54
Sortino edge IBB 0.28 0.79
Calmar edge IBB 0.14 0.32
Reading

IBB returned more: +440.1% to +47.4%. BOND swung less: 4.9% to 23.0%. BOND fell less at its worst: −19.5% to −37.5%.

Full scorecard

9 measures, with how each is measured
Open ↓
Risk and return: BOND vs IBB: Differences, Returns & Fees
MeasureBONDIBBEdgeHow it is measured
Return
Total return+47.4%+440.1%IBBPrice change plus distributions, reinvested.
Annualized+2.7%+12.2%IBBTotal return as a yearly rate.
Price return−12.6%+421.9%IBBPrice change alone, distributions left out.
Risk
Volatility4.9%23.0%BONDSpread of weekly returns, annualized. Lower is steadier.
Downside deviation3.6%15.6%BONDLike volatility, counting only weeks below the Treasury bill rate.
Max drawdown−19.5%−37.5%BONDDeepest fall from a high to the low after it.
Risk-adjusted
Sharpe0.210.54IBBReturn above Treasury bills per unit of volatility.
Sortino0.280.79IBBReturn above Treasury bills per unit of downside deviation.
Calmar0.140.32IBBAnnualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 763 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

0%

By the books each fund has filed, BOND and IBB hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first BOND IBB
Only in one fund ↓
Only in BOND
UMBS, TBA 5.56%
PIMCO Mortgage-Backed Securities Active Exchange-Traded Fund 4.07%
UMBS, TBA 3.46%
United States Treasury 3.40%
UMBS, TBA 2.73%
United States Treasury 2.57%
UMBS, TBA 2.54%
UMBS, TBA 2.27%
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Check overlap with more funds →

Side by side

BOND PIMCO Active Bond Exchange-Traded Fund IBB iShares Biotechnology ETF
Where it sits Bond ETF Thematic ETF
Issuer PIMCO iShares
What it is Actively managed Biotech
Total return, 1 year −1.4% +37.5%
Its benchmark over the same days −1.4% (AGG) not measured
Gap to its benchmark 0.0 pts vs AGG not measured
Expense ratio 0.54% 0.44%
Holdings 1565 245
Net assets, BOND as of Jun 30, 2026 and IBB as of Oct 27, 2026 $8.3bn $11.0bn

BOND and IBB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Client brief

No client brief for this pair: the two funds' holdings are dated 119 days apart.

Alert

IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
BOND

BOND is actively managed and tracks no index. Over the year to Oct 28, 2026 it returned −1.4% with distributions reinvested, against −1.4% for its benchmark, the Bloomberg U.S. Aggregate Index. The prospectus expense ratio is 0.54% a year. It sat 3.1% below its high of Feb 27, 2026 on Oct 28, 2026.

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

Questions people ask

Are BOND and IBB in the same category?
BOND is a bond ETF and IBB is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, BOND or IBB?
In the year to Oct 28, 2026, with distributions reinvested, BOND returned −1.4% and IBB +37.5%.
Which is cheaper, BOND or IBB?
IBB is cheaper, by 0.10 percentage points a year. That is about $10 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, BOND against IBB, data as of Oct 28, 2026. https://etfiq.com/compare/any/bond-vs-ibb

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.